ICU Medical reports Q4 EPS $2.11, consensus $1.48

Reports Q4 revenue $629.8M, consensus $599.1M. Adjusted EBITDA was $105.5 million for the fourth quarter of 2024 as compared to $86.3 million for the fourth quarter of 2023.Vivek Jain, ICU Medical’s (ICUI) Chief Executive Officer, said, “Fourth quarter results were generally in line with our expectations with the exception of higher IV solutions revenues due to the U.S. market shortage.”